Compare FISV & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FISV | CNC |
|---|---|---|
| Founded | 1984 | 1984 |
| Country | United States | United States |
| Employees | 38000 | N/A |
| Industry | Real Estate | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7B | 33.5B |
| IPO Year | N/A | 2001 |
| Metric | FISV | CNC |
|---|---|---|
| Price | $51.91 | $65.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 16 |
| Target Price | ★ $146.17 | $46.75 |
| AVG Volume (30 Days) | ★ 8.5M | 4.0M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.11 |
| Revenue | N/A | ★ $194,777,000,000.00 |
| Revenue This Year | N/A | $8.31 |
| Revenue Next Year | $3.94 | $1.05 |
| P/E Ratio | ★ $9.94 | $21.81 |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $47.04 | $25.08 |
| 52 Week High | $70.41 | $69.29 |
| Indicator | FISV | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 50.78 | 58.90 |
| Support Level | $47.04 | $59.90 |
| Resistance Level | $64.56 | $66.55 |
| Average True Range (ATR) | 1.96 | 2.18 |
| MACD | 0.57 | -0.05 |
| Stochastic Oscillator | 79.71 | 63.10 |
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Following its 2019 merger with First Data, Fiserv also provides payment processing services to merchants. About 10% of the company's revenue is generated internationally.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.